Eléments de l'association

	Remy Hanf	1
	Non-alcoholic Fatty Liver Disease (drug therapy)	1
	Remy Hanf *Sauf* Non-alcoholic Fatty Liver Disease (drug therapy)"	0
	Non-alcoholic Fatty Liver Disease (drug therapy) *Sauf* Remy Hanf"	0
	Remy Hanf Et Non-alcoholic Fatty Liver Disease (drug therapy)	1
	Remy Hanf Ou Non-alcoholic Fatty Liver Disease (drug therapy)	1
	*Corpus*	6045

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000B97	Vlad Ratziu [France] ; Stephen A. Harrison [États-Unis] ; Sven Francque [Belgique] ; Pierre Bedossa [France] ; Philippe Lehert [Belgique] ; Lawrence Serfaty [France] ; Manuel Romero-Gomez ; Jérôme Boursier [France] ; Manal Abdelmalek [États-Unis] ; Steve Caldwell [États-Unis] ; Joost Drenth [Pays-Bas] ; Quentin M. Anstee [Royaume-Uni] ; Dean Hum [France] ; Remy Hanf [France] ; Alice Roudot [France] ; Sophie Megnien [France] ; Bart Staels [France] ; Arun Sanyal [États-Unis]	Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024